Stents having controlled elution
US9775729B2 · kind B2 · utility
26Cited by
252References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2016 |
| Grant date | Oct 3, 2017 |
| Priority date | — |
| Expiry date | Aug 19, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2420/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is a drug delivery system comprising: a. substrate; b. a plurality of components combined with the substrate to form the drug delivery system; wherein at least one components comprises a bioabsorbable polymer and at least one other component comprises one or more active agents; wherein at least part of the active agent is in crystalline form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.